# Garlic Cognition Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/garlic-cognition-randomized-trial-evidence-review
Category: evidence-review
Summary: Garlic Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are syste
Last reviewed: 2026-08-10
Reviewed by: Migaku Evidence Review
# Garlic Cognition Randomized Trial: What the Evidence Says

## Quick Answer

Garlic Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis | systematic review | 1 | 2025-12-19 | 10.3389/fphar.2025.1695614 |
| Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus | research article | 4 | 2026-01-01 | 10.3892/br.2025.2075 |

## What The Sources Report

- Nevertheless, patient adherence is often suboptimal owing to the high costs and varying degrees of adverse effects associated with long-term medication use, such as hypokalemia, bronchospasm, and angioedema. [Deshmukh Saylee (2025); evidence level 1]
- Based on an understanding of Ayurvedic pathophysiology, it may be said that EH occurs due to vitiation of(i.e., body factor responsible for movement and cognition; SAT: B.384) and(i.e., blood tissues; SAT-B.429), which cause vasoconstriction through impaired hormonal actions and lead to increased peripheral resistance. [Deshmukh Saylee (2025); evidence level 1]
- These changes likely contribute to cognitive decline, sensorimotor impairments and increased vulnerability to neurodegenerative disorders. [Mony Tamanna (2026); evidence level 4]
- There is strong evidence indicating the ability of AGE to slow the progression of atherosclerosis, thus serving as a nutraceutical in the primary prevention and mitigation of CVD and stroke. [Mony Tamanna (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For garlic cognition randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Deshmukh Saylee (2025). Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis. DOI: 10.3389/fphar.2025.1695614. PMCID: PMC12757693. PMID: 41487502. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12757693/
- Mony Tamanna (2026). Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus. DOI: 10.3892/br.2025.2075. PMCID: PMC12603483. PMID: 41230016. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution-NonCommercial-NoDerivs License This i.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12603483/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.